Medsafe: depot olanzapine linked with post-injection syndromeNo Abstract available for this article.doi:10.1007/s40278-017-36156-0NoneSpringer International PublishingReactions Weekly
Postinjection Delirium/sedation Syndrome with Olanzapine Depot InjectionByline: Sadhvi. Sarangula, Starlin. Mythri, Y. Sanjay, M. Reddy After 1 year of introduction...Sarangula, SadhviMythri, StarlinSanjay, Y.Reddy, M.Medknow Publications and Media Pvt. Ltd.Indian Journal of Psychological ...
Methods This was a post hoc exploratory analysis of data from a randomized, double-blind study comparing the safety and efficacy of olanzapine-LAI (pooled active depot groups: 405 mg/4 weeks, 300 mg/2 weeks, and 150 mg/2 weeks) with oral olanzapine and sub-therapeutic olanzapine-LAI (45...